Oncternal Therapeutics, Inc.
ONCTDelisted Mar 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001260990
Oncternal Therapeutics, Inc. was delisted on Mar 17, 2025; its insiders filed their last Form 4 on Jun 24, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $471.0K in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Oncternal Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 26 | 1 | 23 | −2 |
| Shares | 483.1K | 39.3K | 357.2K | −86.6K (−19.5%) |
| Value | $3.67M | $298.5K | $471.0K | −$2.90M (−86.0%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Oncternal Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 39,706 | $52.4K | 0.00% |
| Virtu Financial LLC | 12,276 | $16.0K | 0.00% |
| Truvestments Capital LLC | 22 | $29 | 0.00% |
| Danske Bank A/S | 1 | $1 | 0.00% |
Sold out (6)
Institutions that held Oncternal Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Dimensional Fund Advisors LP | 26,298 | $199.9K |
| Richmond Brothers, Inc. | 24,696 | $187.7K |
| Brighton Jones LLC | 16,923 | $128.6K |
| Susquehanna International Group, LLP | 15,206 | $115.6K |
| US Bancorp | 100 | $760 |
| FMR LLC | 72 | $547 |
Not filed for Q3 2024 yet (1)
Institutions that held Oncternal Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 39,278 | $298.5K |